Trialmedsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2017-10-30
Share capital
5,000.00 PLN
Registered address
ul. Korczak 30/16, 62-800 Kalisz, Poland
Electronic delivery address
AE:PL-15834-29584-GGSHV-17
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $2,214 |
Filing timeliness
Financial statements were filed on time, on average 102 days early.
- 202512/03/2026
- 202402/04/2025
- 202302/04/2024
- 202231/03/2023
- 202103/06/2022
- 202006/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Research and experimental development in natural sciences and engineering123 / 277
Top 44%
Results vs industry
Revenue
This companyUSD 228.81kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD 15.09kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 208.13kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 385.30kMedianUSD 278.35kAverageUSD 8.47m
Industry
Trademarks
Trialmed holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2025.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| TRIALMED CLINICAL RESEARCH SITE | Z.585422 | 42 | Protected | May 30, 2035 |
| Mark | Protected until | |
|---|---|---|
| TRIALMED CLINICAL RESEARCH SITE | May 30, 2035 |
Authorized Representatives
Robert Paweł Krakowian – Management Board Member
Piotr Wojciech Pokojowczyk – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Paweł Krakowianage 45 | 50 | $675.31 | 50% |
Piotr Wojciech Pokojowczykage 49 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-12-15.
76 1020 2212 0000 5102 0388 0846
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 12, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| BiocamS.A. | $327,799.68 | biocam.ai | ||
| Pharmacy Research Institutesp. z o.o. | $294,406.08 | pharmacyinstitute.pl | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| ETG Zamośćsp. z o.o. | $260,151.02 | etg-network.com | ||
| Dicellasp. z o.o. | $206,073.49 | dicella.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Nexbiosp. z o.o. | $186,582.40 | nexbio.pl | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| SatroecgS.A. | $117,301.57 | satroecg.pl |
FAQ
The main business activity of Trialmed focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on October 30, 2017.
The headquarters is located at: ul. Korczak 30, 62-800 Kalisz.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 228,811, representing a decrease of 8.9% compared to 2024.
Yes, the company recorded a net profit of USD 15,094 in 2025, meaning the company decreased its profit by 59.9%.
The largest operating cost category falls under other operating costs. This category amounted to USD 135,805 in 2025, representing 65% of all operating expenses.
Last updated: 2026-10-03